Tune into #RFBreakthrough, a don't-miss livestream series highlighting urgent and innovative discussions with thought leaders and industry experts.

From the latest National Covid-19 Testing and Tracing Plan to groundbreaking learnings in artificial intelligence, nutrition, climate change, equity and last-mile electrification, our experts converge to solve pressing problems, improve lives and unleash human potential across the globe.

Have a question about how AI can help rebalance and reset the future? Submit your questions below for our panel of experts and tune in Wednesday, August 19 at 11AM ET for a LIVE #RFBreakthrough conversation.

The Rockefeller Foundation experts will be answering your questions during the LIVE Q&A.

Submit your questions here


Sessions will be broadcasted live across the Foundation’s social media pages
(Twitter, Facebook, LinkedIn and YouTube).


Recent Episodes

  • Episode 01

    Covid-19: a Blueprint for Keeping the U.S. Economy Open

    For our inaugural episode, The Rockefeller Foundation hosted a live-stream discussion, Covid-19: a Blueprint for Keeping the U.S. Economy Open. The panelists discuss the updated national testing, tracing and safety regimen for the United States.
  • Episode 02

    The Future of AI: Developing a Framework that Benefits All

    For the second episode in the #RFBreakthrough series, The Rockefeller Foundation is hosting a live stream discussion on how we can use artificial intelligence as a force for good during the pandemic and beyond, while also exploring the need for a regulatory framework to ensure its responsible use.

Related Updates

Jul 16 2020
Press Releases
The Rockefeller Foundation Launches New Testing Strategy to Keep U.S. Economy Open
May 14 2020
Press Releases
The Rockefeller Foundation Adds New Members to Testing Solutions Group to Expand Pandemic Testing Across U.S.
Apr 20 2020
Press Releases
The Rockefeller Foundation Commits $50 Million in Funding for Global Coronavirus Response in 2020 Annual Letter: “Covid-19: Meeting This Moment”
Back to Top